Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement

被引:0
|
作者
R. Resende Lima Oliveira de Brasil
D. Vieira Soares
L. Diniz Carneiro Spina
P. Marise Lobo
E. Maria Carvalho da Silva
V. Mansur Aleta
M. F. Miguens Castelar Pinheiro
F. L. Conceição
M. Vaisman
机构
[1] Federal University of Rio de Janeiro (UFRJ),Service of Endocrinology, Clementino Fraga Filho University Hospital, Medical School
[2] Previlab-Medical Services Ltda,undefined
[3] Medical Laboratory Sérgio Franco Diagnostic Medicine,undefined
关键词
Insulin resistance; blood pressure; ambulatory monitoring of blood pressure (AMBP); growth hormone; deficiency;
D O I
10.1007/BF03346297
中图分类号
学科分类号
摘要
The GH deficiency syndrome in adults is characterized by changes in body composition, metabolic, cardiovascular and psychological profile. Such alterations fit the metabolic syndrome. Changes of blood pressure (BP) levels related to the presence of insulin resistance (IR) may be present in the GH-deficient adult prior to or after therapy with recombinant GH (hGH). The purpose of the study was to assess the relationship between BP and IR in GH-deficient adults after 24 months of replacement with hGH. Thirteen GH-deficient adults were studied [7 men and 6 women, with an average age of 38.6±14.14 yr body mass index (BMI) 25.83±2.26 kg/m2]. The BP was assessed by means of ambulatory monitoring of BP (AMBP), prior to the treatment and 12 and 24 months after replacement with hGH. Glucose metabolism was assessed by the homeostatic model assessment (HOMA), during the same periods. The average dosage of hGH utilized was 0.67±0.15 mg/day. In the analysis of BP levels, we observed a decrease of the diurnal systolic BP (SBP) (p=0.043) and a reduction of the diurnal systolic (p=0.002) and diastolic pressure loads (p=0.038). During the night there were no changes in BP levels. We observed an increase in the percentage of patients with a non-physiological nocturnal fall (non dippers) after replacement with hGH (61.53%). The mean HOMA, insulin and glucose in the fasting state did not present any statistically significant changes. Although the patients within the non-dipper group had higher HOMA and insulin levels throughout the study, there were no changes in any of these parameters after GH replacement. All patients with HOMA >2.5 were within the non-dipper group, whereas all dippers had HOMA <2.5. In conclusion, 24 months of therapy with hGH do not seem to have affected glucose homeostasis, and since there is no relationship with the increase of the percentage of non-physiological nocturnal fall, we will need a longer observation time to discover the effects of this finding.
引用
收藏
页码:306 / 312
页数:6
相关论文
共 50 条
  • [31] Predictors of Bone Responsiveness to Growth Hormone (GH) Replacement in Adult GH-Deficient Patients
    Alessandro Rossini
    Roberto Lanzi
    Marco Losa
    Marcella Sirtori
    Elisa Gatti
    Sara Madaschi
    Chiara Molinari
    Isabella Villa
    Marina Scavini
    Alessandro Rubinacci
    Calcified Tissue International, 2011, 88 : 304 - 313
  • [32] Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood
    Longobardi, S
    Merola, B
    Pivonello, R
    DiRella, F
    DiSomma, C
    Colao, A
    Ghigo, E
    Camanni, F
    Lombardi, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03): : 1244 - 1247
  • [33] Effect of growth hormone (GH) therapy on endothelial function in GH-deficient adults
    Smith, JC
    Evans, LM
    Davies, JS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12): : 4749 - 4750
  • [34] The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults
    Cuneo, RC
    Judd, S
    Wallace, JD
    Perry-Keene, D
    Burger, H
    Lim-Tio, S
    Strauss, B
    Stockigt, J
    Topliss, D
    Alford, F
    Hew, L
    Bode, H
    Conway, A
    Handelsman, D
    Dunn, S
    Boyages, S
    Cheung, NW
    Hurley, D
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01): : 107 - 116
  • [35] GH-deficient men are more responsive to GH replacement therapy than women - Response
    Burman, P
    Johansson, AG
    EdenEngstrom, B
    Karlsson, FA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10): : 3515 - 3515
  • [36] Predictors of Bone Responsiveness to Growth Hormone (GH) Replacement in Adult GH-Deficient Patients
    Rossini, Alessandro
    Lanzi, Roberto
    Losa, Marco
    Sirtori, Marcella
    Gatti, Elisa
    Madaschi, Sara
    Molinari, Chiara
    Villa, Isabella
    Scavini, Marina
    Rubinacci, Alessandro
    CALCIFIED TISSUE INTERNATIONAL, 2011, 88 (04) : 304 - 313
  • [37] Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients
    Colao, A
    Di Somma, C
    Spiezia, S
    Filippella, M
    Pivonello, R
    Lombardi, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01): : 88 - 94
  • [38] Short- and long-term effects of growth hormone (GH) replacement on protein metabolism in GH-deficient adults
    Shi, JJ
    Sekhar, RV
    Balasubramanyam, A
    Ellis, K
    Reeds, PJ
    Jahoor, F
    Sharma, MD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12): : 5827 - 5833
  • [39] Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacement
    Oomen, PHN
    Beentjes, JAM
    Bosma, E
    Smit, AJ
    Reitsma, WD
    Dullaart, RPF
    CLINICAL ENDOCRINOLOGY, 2002, 56 (04) : 519 - 524
  • [40] Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults
    Mukherjee, A
    Adams, JE
    Smethurst, L
    Shalet, SM
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (05) : 661 - 668